Annovis Bio Inc. (ANVS)
4.72
0.05 (1.07%)
At close: Jan 15, 2025, 11:53 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -45.04M | -25.51M | -14.54M | -6.64M | -1.61M | -713.94K | -682.43K |
| Interest Income | 667.90M | 182.71K | 13.34K | 47.23K | n/a | n/a | n/a |
| Pretax Income | -56.20M | -25.33M | -14.49M | -5.46M | -990.98K | -713.87K | -682.35K |
| Net Income | -56.20M | -25.15M | -14.44M | -4.26M | -296.84K | -713.87K | -682.35K |
| Selling & General & Admin | 6.24M | 9.00M | 6.06M | 3.59M | 829.37K | 602.33K | 409.06K |
| Research & Development | 38.79M | 16.52M | 8.48M | 3.05M | 776.26K | 111.61K | 273.37K |
| Other Expenses | n/a | n/a | -36.75K | -1.16M | -735.08K | n/a | n/a |
| Operating Expenses | 45.04M | 25.51M | 14.50M | 5.48M | 870.55K | 713.94K | 682.43K |
| Interest Expense | n/a | n/a | n/a | 47.23M | n/a | 66.00 | 84.00 |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 45.04M | 25.51M | 14.50M | 5.48M | 870.55K | 713.94K | 682.43K |
| Income Tax | n/a | -182.71K | -50.09K | -1.20M | -694.14K | -132 | -682.43K |
| Shares Outstanding (Basic) | 9.02M | 8.16M | 7.63M | 6.31M | 4.50M | 4.40M | 4.39M |
| Shares Outstanding (Diluted) | 9.02M | 8.16M | 7.63M | 6.31M | 4.50M | 4.40M | 4.39M |
| EPS (Basic) | -6.23 | -3.08 | -1.89 | -0.67 | -0.07 | -0.16 | -0.16 |
| EPS (Diluted) | -6.23 | -3.08 | -1.89 | -0.67 | -0.07 | -0.16 | -0.16 |
| EBITDA | -45.04M | n/a | n/a | n/a | n/a | 66.00 | 84.00 |
| Depreciation & Amortization | 1.00 | 25.51M | 14.54M | 6.64M | 1.61M | 713.94K | 682.43K |